Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $14.8800 (-23.1%) ($14.0100 - $17.0500) on Mon. Mar. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.87% (three month average) | RSI | 34 | Latest Price | $14.8800(-23.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -6.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(59%) IWO(58%) XBI(58%) IBUY(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.435% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-7%) TLT(-2%) TBT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.435% (StdDev 4.87%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
1 - 5 Day Possible Target | $-3.31(-122.24%) | Resistance Level | $22.27 | 5 Day Moving Average | $18.79(-20.81%) | 10 Day Moving Average | $20.78(-28.39%) | 20 Day Moving Average | $22.27(-33.18%) | To recent high | -54.6% | To recent low | 0% | Market Cap | $924m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |